Should everyone get a heart scan to decide on statins? A large new trial says the answer is not so simple. The CorCal Outcomes trial, presented as a Hot Line study at ESC Congress 2026, tested whether a coronary calcium scan could guide statin decisions as well as the traditional risk score. It did not prove that it could.
What the Statin Decisions Trial Tested
According to a ScienceDaily report on the European Society of Cardiology release, researchers randomized 5,772 patients 1:1 at Intermountain Health Care in the U.S. The average age was 64, 51% were women, and the average follow-up was 4.2 years.
One group had statin decisions guided by a coronary artery calcium scan. The other group used the traditional risk-score approach.
The Results in Plain English
| Measure | Result |
|---|---|
| Major cardiovascular events | 2.7% in each group |
| Hazard ratio | 0.99 (95% CI 0.71-1.38) |
| Statin recommendations | More than 3 times as often in the risk-score group |
| Statin adherence | 62% (calcium scan) vs 23% (risk score) |
Event rates were the same, but the trial did not demonstrate noninferiority, meaning it could not formally show the scan approach was no worse. The report listed a p-value of 0.045 for noninferiority.
Why the Adherence Gap Stands Out
Patients guided by a calcium scan were far more likely to stay on statins: 62% versus 23%. Seeing a personal result may be motivating, though the study report does not prove why.
The scan group also received fewer statin recommendations overall, yet had the same rate of major events. That raises a practical question about whether some people are prescribed medicine they may not need, and whether others stop taking it because the reason feels abstract.
What You Should Do
- Do not stop a statin on your own. Talk to your clinician first.
- Ask about your risk: Questions about family history, cholesterol and blood pressure are a good start.
- Ask whether a calcium scan makes sense for you. It is one tool, not a universal answer.
For more on food and heart-friendly habits, read our report on full-fat dairy and cholesterol and on coffee and dementia risk.
What Is a Coronary Calcium Scan?
A coronary artery calcium scan is a quick heart CT test that looks for calcium deposits in the walls of the arteries that feed the heart. Calcium is a marker of plaque buildup. A score of zero generally suggests very little plaque, while higher scores suggest more. Doctors use the result alongside other information, such as age, blood pressure, cholesterol and family history.
What Is a Traditional Risk Score?
The traditional approach uses a calculator that estimates your chance of a heart attack or stroke over the next ten years based on factors like age, sex, cholesterol, blood pressure, diabetes and smoking. It is inexpensive and widely used. Its limitation is that it estimates risk for groups of people who look similar on paper, not for your own arteries.
How to Read Noninferiority Results
In a noninferiority trial, researchers test whether a new approach is not meaningfully worse than the standard one. Even when two groups have the same event rate, as they did here at 2.7% each, a trial can fail to formally show noninferiority if the confidence range is wide. The reported range ran from 0.71 to 1.38, which leaves room for both a modest benefit and a modest harm. That is why the authors’ conclusion is cautious.
Questions to Bring to Your Appointment
- What is my estimated ten-year risk, and which factors drive it most?
- Would a calcium scan change what we decide about a statin?
- If I start a statin, how will we track whether it is working and whether I tolerate it?
- What lifestyle changes could lower my risk, regardless of medication?
This is general information, not medical advice. Your own doctor can tailor guidance to you.
1 thought on “Statin Decisions: Big 5,772-Patient Trial Questions Calcium-Scan Approach”